ATH
Alterity Therapeutics
Pharmaceuticals, Biotechnology & Life Sciences
Alterity Therapeutics Limited focuses on developing therapies to treat neurodegenerative diseases associated with aging, like Alzheimer's and Parkinson's disease. The company leverages a novel drug development platform aimed at targeting misfolded proteins. Positioned as a pioneer in this field, Alterity aims to address significant unmet needs in the neurosciences market.
biotechnology
neurodegenerative diseases
therapeutic development
pharmaceuticals
Shorted
short percentage0.19%
reported shorts20.3M
shares on issue10.875B